个人简介:
王璐红,理学博士,助理研究员。
研究方向:
1、靶向小分子抑制剂的设计、合成与优化
2、肿瘤耐药机制的研究
教育经历:
2019.9-2023.10 沈阳药科大学-药物化学-博士
2016.9-2019.6 大连医科大学-药物化学-硕士
2012.8-2016.6 大连医科大学-药学-学士
工作经历:2023.11-至今 大连理工大学医学部-博士后
论文成果:
[1] Luhong Wang, Fei Xie, Shujing Li, Guanglu Guo, Qiyu Song, Xinyu Yuan, Jie Kang, Yulin Li, Aoli Wang, Huijian Wu, Youjun Xu. Pan-EGFR inhibitor targeting EGFR 19del, L858R/T790M and C797S triple-mutations: Design, synthesis, and pharmacological evaluation. Bioorganic chemistry, 2025, 164, 108878.
[2] Luhong Wang, Yong Zhang, Tao Yu, Huijian Wu. The Role and Mechanism of Deubiquitinase USP7 in Tumor-Associated Inflammation. Biomedicines, 2024, 12, 2734.
[3] Luhong Wang, Xueting Ding, Kai Wang, Ruchan Sun, Ming Li, Fang Wang, Youjun Xu. Structure-based modification of ortho-amidophenyl aminopyrimidines as a novel mutant EGFR inhibitor against resistant non-small cell lung cancer. Journal of Molecular Structure, 2023, 1274, 134499.
[4] Luhong Wang, Min Ai, Jiawen Yu, Lingling Jin, Changyuan Wang, Zhihao Liu, Xiaohong Shu, Zeyao Tang, Kexin Liu, Hui Luo, Wenshun Guan, Xiuli Sun, Xiaodong Ma. Structure-based modification of carbonyl- diphenylpyrimidines (Car-DPPYs) as a novel focal adhesion kinase (FAK) inhibitor against various stubborn cancer cells. European Journal of Medical Chemistry, 2019, 172, 154‒162.